[1]
|
Archer, V.R., Billingham, L.J. and Cullen, M.H. (1999) Palliative Chemotherapy: No Longer a Contradiction in Terms. Oncologist, 4, 470-477.
https://doi.org/10.1634/theoncologist.4-6-470
|
[2]
|
Chan, W.L., Yuen, K.K., Siu, S.W., Lam, K.O. and Kwong, D.L. (2017) Third-Line Systemic Treatment versus Best Supportive Care for Advanced/Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis. Critical Reviews in Oncology/Hematology, 116, 68-81. https://doi.org/10.1016/j.critrevonc.2017.05.002
|
[3]
|
Crosara Teixeira, M., Marques, D.F., Ferrari, A.C., Alves, M.F., Alex, A.K., Sabbaga, J., Hoff, P.M. and Riechelmann, R.P. (2015) The Effects of Palliative Chemotherapy in Metastatic Colorectal Cancer Patients with an ECOG Performance Status of 3 and 4. Clinical Colorectal Cancer, 14, 52-57.
https://doi.org/10.1016/j.clcc.2014.09.010
|
[4]
|
Kim, J.W., Kim, J.G., Kang, B.W., Chung, I.J., Hong, Y.S., Kim, T.Y., Song, H.S., Lee, K.H., Zang, D.Y., Ko, Y.H., Song, E.K., Baek, J.H., Koo, D.H., Oh, S.Y., Cho, H. and Lee, K.W. (2019) Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer. Cancer Research and Treatment, 51, 223-239.
https://doi.org/10.4143/crt.2018.073
|
[5]
|
Penson, R.T., Wenzel, L.B., Vergote, I. and Cella, D. (2006) Quality of Life Considerations in Gynecologic Cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynecology & Obstetrics, 95, S247-S257. https://doi.org/10.1016/S0020-7292(06)60040-4
|
[6]
|
Carey, M.S., Bacon, M., Tu, D., Butler, L., Bezjak, A. and Stuart, G.C. (2008) The Prognostic Effects of Performance Status and Quality of Life Scores on Progression-Free Survival and Overall Survival in Advanced Ovarian Cancer. Gynecologic Oncology, 108, 100-105. https://doi.org/10.1016/j.ygyno.2007.08.088
|
[7]
|
Tsuboi, R., Sugishita, M., Hirakawa, Y. and Ando, Y. (2020) Experiences and Hidden Needs of Older Patients, Their Families and Their Physicians in Palliative Chemotherapy Decision-Making: A Qualitative Study. Japanese Journal of Clinical Oncology, 50, 779-786. https://doi.org/10.1093/jjco/hyaa020
|
[8]
|
Dignan, F., Seiden, M.V., Lee, H., Gallagher, C.J., Matulonis, U.A., Olson, K., Gibbens, I. and Gore, M.E. (2004) Attitudes to Chemotherapy in Patients with Ovarian Cancer. Gynecologic Oncology, 94, 427-435.
https://doi.org/10.1016/j.ygyno.2004.05.034
|
[9]
|
Jansen, L., Hoffmeister, M., Chang-Claude, J., Koch, M., Brenner, H. and Arndt, V. (2011) Age-Specific Administration of Chemotherapy and Long-Term Quality of Life in Stage II and III Colorectal Cancer Patients: A Population-Based Prospective Cohort. Oncologist, 16, 1741-1751. https://doi.org/10.1634/theoncologist.2011-0124
|
[10]
|
Jansen, K., Haugen, D.F., Pont, L. and Ruths, S. (2018) Safety and Effectiveness of Palliative Drug Treatment in the Last Days of Life—A Systematic Literature Review. Journal of Pain and Symptom Management, 55, 508-521.E3.
https://doi.org/10.1016/j.jpainsymman.2017.06.010
|
[11]
|
von Gruenigen, V.E., Huang, H.Q., Gil, K.M., Frasure, H.E., Armstrong, D.K. and Wenzel, L.B. (2012) The Association between Quality of Life Domains and Overall Survival in Ovarian Cancer Patients during Adjuvant Chemotherapy: A Gynecologic Oncology Group Study. Gynecologic Oncology, 124, 379-382.
https://doi.org/10.1016/j.ygyno.2011.11.032
|
[12]
|
Morton, L.M., Dores, G.M., Schonfeld, S.J., Linet, M.S., Sigel, B.S., Lam, C.J., Curtis, R.E., et al. (2019) Association of Chemotherapy for Solid Tumors with Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era. JAMA Oncology, 5, 318-325.
https://doi.org/10.1001/jamaoncol.2018.5625
|
[13]
|
Tschernichovsky, R., Philp, L. and Goodman, A. (2019) Chemotherapy-Induced Cognitive Decline: Moving from the Mechanistic Debate towards Prevention and Treatment—A Clinical Review. Journal of Cancer Therapy, 10, 985-1012.
https://doi.org/10.4236/jct.2019.1012084
|
[14]
|
Park, S.B., Krishnan, A.V., Lin, C.S., Goldstein, D., Friedlander, M. and Kiernan, M.C. (2008) Mechanisms Underlying Chemotherapy-Induced Neurotoxicity and the Potential for Neuroprotective Strategies. Current Medicinal Chemistry, 15, 3081-3094. https://doi.org/10.2174/092986708786848569
|
[15]
|
Young, K. and Singh, G. (2018) Biological Mechanisms of Cancer-Induced Depression. Frontiers in Psychiatry, 9, Article No. 299.
https://doi.org/10.3389/fpsyt.2018.00299
|
[16]
|
Fabbrocini, G., Cameli, N., Romano, M.C., Mariano, M., Panariello, L., Bianca, D. and Monfrecola, G. (2012) Chemotherapy and Skin Reactions. Journal of Experimental & Clinical Cancer Research: CR, 31, Article No. 50.
https://doi.org/10.1186/1756-9966-31-50
|
[17]
|
Bhalla, K.S., Wilczynski, S.W., Abushamaa, A.M., Petros, W.P., McDonald, C.S., Loftis, J.S., Chao, N.J., Vredenburgh, J.J. and Folz, R.J. (2000) Pulmonary Toxicity of Induction Chemotherapy Prior to Standard or High-Dose Chemotherapy with Autologous Hematopoietic Support. American Journal of Respiratory and Critical Care Medicine, 161, 17-25. https://doi.org/10.1164/ajrccm.161.1.9903059
|
[18]
|
Florescu, M., Cinteza, M. and Vinereanu, D. (2013) Chemotherapy-Induced Cardiotoxicity. Maedica, 8, 59-67.
|
[19]
|
Forsgard, R.A., Marrachelli, V.G., Korpela, K., Frias, R., Collado, M.C., Korpela, R., Monleon, D., Spillmann, T. and Österlund, P. (2017) Chemotherapy-Induced Gastrointestinal Toxicity Is Associated with Changes in Serum and Urine Metabolome and Fecal Microbiota in Male Sprague-Dawley Rats. Cancer Chemotherapy and Pharmacology, 80, 317-332. https://doi.org/10.1007/s00280-017-3364-z
|
[20]
|
Wong, T.M., Yeo, W., Chan, L.W. and Mok, T.S. (2000) Hemorrhagic Pyelitis, Ureteritis, and Cystitis Secondary to Cyclophosphamide: Case Report and Review of the Literature. Gynecologic Oncology, 76, 223-225.
https://doi.org/10.1006/gyno.1999.5680
|
[21]
|
Wang, Y., Probin, V. and Zhou, D. (2006) Cancer Therapy-Induced Residual Bone Marrow Injury-Mechanisms of Induction and Implication for Therapy. Current Cancer Therapy Reviews, 2, 271-279. https://doi.org/10.2174/157339406777934717
|
[22]
|
Mangan, B.L., McAlister, R.K., Balko, J.M., Johnson, D.B., Moslehi, J.J., Gibson, A. and Phillips, E.J. (2020) Evolving Insights into the Mechanisms of Toxicity Associated with Immune Checkpoint Inhibitor Therapy. British Journal of Clinical Pharmacology, 86, 1778-1789. https://doi.org/10.1111/bcp.14433
|
[23]
|
Gough, N., Koffman, J., Ross, J.R., Riley, J. and Judson, I. (2019) Does Palliative Chemotherapy Really Palliate and Are We Measuring It Correctly? A Mixed Methods Longitudinal Study of Health-Related Quality of Life in Advanced Soft Tissue Sarcoma. PLoS ONE, 14, e0210731.
https://doi.org/10.1371/journal.pone.0210731
|
[24]
|
Markman, M. (2006) Palliative Chemotherapy “Near the End-of-Life” in Ovarian Cancer: Not Necessarily “Aggressive Cure-Oriented Therapy”. Gynecologic Oncology, 101, 198-199. https://doi.org/10.1016/j.ygyno.2006.01.008
|
[25]
|
Fiorin de Vasconcellos, V., Rcc Bonadio, R., Avanço, G., Negrão, M.V. and Pimenta and Riechelmann, R. (2019) Inpatient Palliative Chemotherapy Is Associated with High Mortality and Aggressive End-of-Life Care in Patients with Advanced Solid Tumors and Poor Performance Status. BMC Palliative Care, 18, Article No. 42.
https://doi.org/10.1186/s12904-019-0427-4
|
[26]
|
Lee, M.W., Ryu, H., Song, I.C., Yun, H.J., Jo, D., Ko, Y.B. and Lee, H.J. (2020) Efficacy of Cisplatin Combined with Topotecan in Patients with Advanced Or Recurrent Ovarian Cancer as Second- or Higher-Line Palliative Chemotherapy. Medicine (Baltimore), 99, e19931. https://doi.org/10.1097/MD.0000000000019931
|
[27]
|
Zhang, B., Nilsson, M.E. and Prigerson, H.G. (2012) Factors Important to Patients’ Quality of Life at the End of Life. Archives of Internal Medicine, 172, 1133-1142.
https://doi.org/10.1001/archinternmed.2012.2364
|
[28]
|
Sheffield, K.M., Boyd, C.A., Benarroch-Gampel, J., Kuo, Y.F., Cooksley, C.D. and Riall, T.S. (2011) End-of-Life Care in Medicare Beneficiaries Dying with Pancreatic Cancer. Cancer, 117, 5003-5012. https://doi.org/10.1002/cncr.26115
|
[29]
|
Verhoef, M.J., de Nijs, E.J.M., Ootjers, C.S., Fiocco, M., Fogteloo, A.J., Heringhaus, C., Marijnen, C.A.M., Horeweg, N. and der Linden, Y.M.V. (2020) End-of-Life Trajectories of Patients with Hematological Malignancies and Patients with Advanced Solid Tumors Visiting the Emergency Department: The Need for a Proactive Integrated Care Approach. American Journal of Hospice and Palliative Care, 37, 692-700.
https://doi.org/10.1177/1049909119896533
|
[30]
|
Wright, A.A., Zhang, B., Ray, A., Mack, J.W., Trice, E., Balboni, T., Mitchell, S.L., Jackson, V.A., Block, S.D., Maciejewski, P.K. and Prigerson, H.G. (2008) Associations between End-of-Life Discussions, Patient Mental Health, Medical Care near Death, and Caregiver Bereavement Adjustment. JAMA, 300, 1665-1673.
https://doi.org/10.1001/jama.300.14.1665
|
[31]
|
Earle, C.C., Neville, B.A., Landrum, M.B., Ayanian, J.Z., Block, S.D. and Weeks, J.C. (2004) Trends in the Aggressiveness of Cancer Care near the End of Life. Journal of Clinical Oncology, 22, 315-321. https://doi.org/10.1200/JCO.2004.08.136
|
[32]
|
Deeb, S., Chino, F.L., Diamond, L.C., Tao, A., Aragones, A., Shahrokni, A., Yerramilli, D., Gillespie, E.F. and Tsai, C.J. (2021) Disparities in Care Management during Terminal Hospitalization among Adults with Metastatic Cancer from 2010 to 2017. JAMA Network Open, 4, e2125328.
https://doi.org/10.1001/jamanetworkopen.2021.25328
|
[33]
|
Tay, R.Y., Choo, R.W.K., Ong, W.Y. and Hum, A.Y.M. (2021) Predictors of the Final Place of Care of Patients with Advanced Cancer Receiving Integrated Home-Based Palliative Care: A Retrospective Cohort Study. BMC Palliative Care, 20, Article No. 164. https://doi.org/10.1186/s12904-021-00865-5
|
[34]
|
Wright, A.A., Zhang, B., Keating, N.L., Weeks, J.C. and Prigerson, H.G. (2014) Associations between Palliative Chemotherapy and Adult Cancer Patients’ End of Life Care and Place of Death: Prospective Cohort Study. BMJ, 348, g1219.
https://doi.org/10.1136/bmj.g1219
|
[35]
|
von Gruenigen, V., Daly, B., Gibbons, H., Hutchins, J. and Green, A. (2008) Indicators of Survival Duration in Ovarian Cancer and Implications for Aggressiveness of Care. Cancer, 112, 2221-2227. https://doi.org/10.1002/cncr.23391
|
[36]
|
von Gruenigen, V.E., Huang, H.Q., Beumer, J.H., Lankes, H., Tew, W., Herzog, T., Hurria, A., Mannel, R.S., Rizack, T., Landrum, L.M., Rose, P.G., Salani, R., Bradley, W.H., Rutherford, T.J., Higgins, R.V., Secord, A.A. and Fleming, G. (2017) Chemotherapy Completion in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer—An NRG Oncology/Gynecologic Oncology Group Study. Gynecologic Oncology, 144, 459-467. https://doi.org/10.1016/j.ygyno.2016.11.033
|
[37]
|
Saito, A.M., Landrum, M.B., Neville, B.A., et al. (2011) The Effect on Survival of Continuing Chemotherapy to Near Death. BMC Palliative Care, 10, Article No. 14.
https://doi.org/10.1186/1472-684X-10-14
|
[38]
|
Yun, Y.H., Kwak, M., Park, S.M., Kim, S., Choi, J.S., Lim, H.Y., Lee, C.G., Choi, Y.S., Hong, Y.S., Kim, S.Y. and Heo, D.S. (2007) Chemotherapy Use and Associated Factors among Cancer Patients near the End of Life. Oncology, 72, 164-171.
https://doi.org/10.1159/000112802
|
[39]
|
Lee, Y.P., Wu, C.H., Chiu, T.Y., Chen, C.Y., Morita, T., Hung, S.H., Huang, S.B., Kuo, C.S. and Tsai, J.S. (2015) The Relationship between Pain Management and Psychospiritual Distress in Patients with Advanced Cancer Following Admission to a Palliative Care Unit. BMC Palliative Care, 14, Article No. 69.
https://doi.org/10.1186/s12904-015-0067-2
|
[40]
|
Yoshida, Y. (2019) Current Treatment of Older Patients with Recurrent Gynecologic Cancer. Current Opinion in Obstetrics and Gynecology, 31, 340-344.
https://doi.org/10.1097/GCO.0000000000000543
|
[41]
|
Andreis, F., Rizzi, A., Rota, L., Meriggi, F., Mazzocchi, M. and Zaniboni, A. (2011) Chemotherapy Use at the End of Life. A Retrospective Single Centre Experience Analysis. Tumori, 97, 30-34. https://doi.org/10.1177/030089161109700106
|
[42]
|
Harrington, S.E. and Smith, T.J. (2008) The Role of Chemotherapy at the End of Life: “When Is Enough, Enough?” JAMA, 299, 2667-2678.
https://doi.org/10.1001/jama.299.22.2667
|
[43]
|
Braga, S. (2011) Why Do Our Patients Get Chemotherapy until the End of Life? Annals of Oncology, 22, 2345-2348. https://doi.org/10.1093/annonc/mdr416
|
[44]
|
Näppä, U., Lindqvist, O., Rasmussen, B.H. and Axelsson, B. (2011) Palliative Chemotherapy during the Last Month of Life. Annals of Oncology, 22, 2375-2380.
https://doi.org/10.1093/annonc/mdq778
|
[45]
|
Weisman, D.E. and von Gunten, C.F. (2003) Fast Fact and Concept #099: Chemotherapy: Response and Survival Data. From Fast Facts Index.
https://www.mywhatever.com/cifwriter/library/eperc/fastfact/ff99.html
|
[46]
|
Baldotto, C.S., Cronemberger, E.H., de Biasi, P., Zamboni, M., Sousa, A., Zukin, M., Small, I.A. and Ferreira, C.G. (2012) Palliative Care in Poor-Performance Status Small Cell Lung Cancer Patients: Is There a Mandatory Role for Chemotherapy? Supportive Care in Cancer, 20, 2721-2727.
https://doi.org/10.1007/s00520-012-1392-0
|
[47]
|
Berger, A.K., Zschaebitz, S., Komander, C., Jäger, D. and Haag, G.M. (2015) Palliative Chemotherapy for Gastroesophageal Cancer in Old and Very Old Patients: A Retrospective Cohort Study at the National Center for Tumor Diseases, Heidelberg. World Journal of Gastroenterology, 21, 4911-4918.
https://doi.org/10.3748/wjg.v21.i16.4911
|
[48]
|
Lichtman, S.M. (2014) How I Treat Ovarian Cancer in Older Women. Journal of Geriatric Oncology, 5, 223-229. https://doi.org/10.1016/j.jgo.2014.06.001
|
[49]
|
Li, Q., Lin, Y., Qiu, Y., Gao, B. and Xu, Y. (2014) The Assessment of Health-Related Quality of Life and Related Factors in Chinese Elderly Patients Undergoing Chemotherapy for Advanced Cancer: A Cross-Sectional Study. The European Journal of Oncology Nursing, 18, 425-435. https://doi.org/10.1016/j.ejon.2014.03.005
|
[50]
|
Tew, W.P. (2016) Ovarian Cancer in the Older Woman. Journal of Geriatric Oncology, 7, 354-361. https://doi.org/10.1016/j.jgo.2016.07.008
|
[51]
|
Kao, S., Shafiq, J., Vardy, J. and Adams, D. (2009) Use of Chemotherapy at End of Life in Oncology Patients. Annals of Oncology, 20, 1555-1559.
https://doi.org/10.1093/annonc/mdp027
|
[52]
|
Prigerson, H.G., Bao, Y., Shah, M.A., et al. (2015) Chemotherapy Use, Performance Status, and Quality of Life at the End of Life. JAMA Oncology, 1, 778-784.
https://doi.org/10.1001/jamaoncol.2015.2378
|
[53]
|
Griffiths, R.W., Zee, Y.K., Evans, S., Mitchell, C.L., Kumaran, G.C., Welch, R.S., Hasan, J., et al. (2011) Outcomes after Multiple Lines of Chemotherapy for Platinum-Resistant Epithelial Cancers of the Ovary, Peritoneum, and Fallopian Tube. International Journal of Gynecologic Cancer, 21, 58-65.
https://doi.org/10.1097/IGC.0b013e3182049273
|
[54]
|
Pujade-Lauraine, E., Hilpert, F., Weber, B., Reuss, A., Poveda, A., Kristensen, G., Sorio, R., Vergote, I., Witteveen, P., Bamias, A., Pereira, D., Wimberger, P., Oaknin, A., Mirza, M.R., Follana, P., Bollag, D. and Ray-Coquard, I. (2014) Bevacizumab Combined with Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial. Journal of Clinical Oncology, 32, 1302-1308. https://doi.org/10.1200/JCO.2013.51.4489
|
[55]
|
Mayrbäurl, B., Giesinger, J.M., Burgstaller, S., Piringer, G., Holzner, B. and Thaler, J. (2016) Quality of Life across Chemotherapy Lines in Patients with Advanced Colorectal Cancer: A Prospective Single-Center Observational Study. Supportive Care in Cancer, 24, 667-674. https://doi.org/10.1007/s00520-015-2828-0
|
[56]
|
Coleman, R.L. (2016) Insights into Strategies for Optimizing Ovarian Cancer Care. Nature Reviews Clinical Oncology, 13, 71-72.
https://doi.org/10.1038/nrclinonc.2015.225
|
[57]
|
Mansi, L., Demarchi, M., Bazan, F., Delroeux, D., Chaigneau, L., Thiery-Vuillemin, A., Kalbacher, E., et al. (2016) Impact of Chemotherapy beyond the Third Line in Patients with Recurrent Epithelial Ovarian Cancer. International Journal of Gynecologic Cancer, 26, 261-267. https://doi.org/10.1097/IGC.0000000000000592
|
[58]
|
Viganó, A., Bruera, E., Jhangri, G.S., Newman, S.C., Fields, A.L. and Suarez-Almazor, M.E. (2000) Clinical Survival Predictors in Patients with Advanced Cancer. Archives of Internal Medicine, 160, 861-868. https://doi.org/10.1001/archinte.160.6.861
|
[59]
|
Gramling, R., Stanek, S., Han, P.J., Duberstein, P., Quill, T.E., Temel, J.S., Alexander, S.C. anderson, W.G., Ladwig, S. and Norton, S.A. (2018) Distress Due to Prognostic Uncertainty in Palliative Care: Frequency, Distribution, and Outcomes among Hospitalized Patients with Advanced Cancer. Journal of Palliative Medicine, 21, 315-321. https://doi.org/10.1089/jpm.2017.0285
|
[60]
|
Chu, C. anderson, R., White, N. and Stone, P. (2020) Prognosticating for Adult Patients with Advanced Incurable Cancer: A Needed Oncologist Skill. Current Treatment Options in Oncology, 21, Article No. 5.
https://doi.org/10.1007/s11864-019-0698-2
|
[61]
|
Temel, J.S., Greer, J.A., Admane, S., Gallagher, E.R., Jackson, V.A., Lynch, T.J., Lennes, I.T., Dahlin, C.M. and Pirl, W.F. (2011) Longitudinal Perceptions of Prognosis and Goals of Therapy in Patients with Metastatic Non-Small-Cell Lung Cancer: Results of a Randomized Study of Early Palliative Care. Journal of Clinical Oncology, 29, 2319-2326. https://doi.org/10.1200/JCO.2010.32.4459
|
[62]
|
Mack, J.W., Wolfe, J., Cook, E.F., Grier, H.E., Cleary, P.D. and Weeks, J.C. (2007) Hope and Prognostic Disclosure. Journal of Clinical Oncology, 25, 5636-5642.
https://doi.org/10.1200/JCO.2007.12.6110
|
[63]
|
Smith, T.J. and Bodurtha, J.N. (1995) Ethical Considerations in Oncology: Balancing the Interests of Patients, Oncologists, and Society. Journal of Clinical Oncology, 13, 2464-2470. https://doi.org/10.1200/JCO.1995.13.9.2464
|
[64]
|
Dang, B.N., Westbrook, R.A., Njue, S.M., et al. (2017) Building Trust and Rapport Early in the New Doctor-Patient Relationship: A Longitudinal Qualitative Study. BMC Medical Education, 17, Article No. 32.
https://doi.org/10.1186/s12909-017-0868-5
|
[65]
|
Palaia, I., Tomao, F., Santangelo, G., Di Pinto, A., Sassu, C.M., Perniola, G., Musella, A., Di Donato, V., Giancotti, A. and Panici, P.B. (2019) The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life. Oncology, 97, 306-310. https://doi.org/10.1159/000501721
|
[66]
|
Lennes, I.T., Temel, J.S., Hoedt, C., Meilleur, A. and Lamont, E.B. (2013) Predictors of Newly Diagnosed Cancer Patients’ Understanding of the Goals of Their Care at Initiation of Chemotherapy. Cancer, 119, 691-699.
https://doi.org/10.1002/cncr.27787
|
[67]
|
Simpkin, A.L. and Armstrong, K.A. (2019) Communicating Uncertainty: A Narrative Review and Framework for Future Research. Journal of General Internal Medicine, 34, 2586-2591. https://doi.org/10.1007/s11606-019-04860-8
|
[68]
|
Kiely, B.E., Soon, Y.Y., Tattersall, M.H. and Stockler, M.R. (2011) How Long Have I Got? Estimating Typical, Best-Case, and Worst-Case Scenarios for Patients Starting First-Line Chemotherapy for Metastatic Breast Cancer: A Systematic Review of Recent Randomized Trials. Journal of Clinical Oncology, 29, 456-463.
https://doi.org/10.1200/JCO.2010.30.2174
|
[69]
|
Demirelli, B., Babacan, N.A., Ercelep, Ö., Öztürk, M.A., Kaya, S., Tanrikulu, E., Khalil, S., Hasanov, R., Alan, Ö., Telli, T.A., Koca, S., Aribal, M.E., Kuzan, B., Dane, F. and Yumuk, P.F. (2021) Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer. Nutrition and Cancer, 73, 230-238. https://doi.org/10.1080/01635581.2020.1749290
|
[70]
|
Finlayson, C.S., Chen, Y.T. and Fu, M.R. (2015) The Impact of Patients’ Awareness of Disease Status on Treatment Preferences and Quality of Life among Patients with Metastatic Cancer: A Systematic Review from 1997-2014. Journal of Palliative Medicine, 18, 176-186. https://doi.org/10.1089/jpm.2014.0222
|
[71]
|
Shatri, H., Putranto, R., Irawan, C., Adli, M. and Elita, D. (2019) Characteristics of Palliative Patients, Insights of Patients and Families, and the Impact of Estimated Survival Time on Therapy Decisions. Acta Medica Indonesiana, 51, 151-157.
|
[72]
|
Peele, P.B., Siminoff, L.A., Xu, Y. and Ravdin, P.M. (2005) Decreased Use of Adjuvant Breast Cancer Therapy in a Randomized Controlled Trial of a Decision Aid with Individualized Risk Information. Medical Decision Making, 25, 301-307.
https://doi.org/10.1177/0272989X05276851
|
[73]
|
Creutzfeldt, A., Suling, A., Oechsle, K., Mehnert, A., Atanackovic, D., Kripp, M., Arnold, D., Stein, A. and Quidde, J. (2016) Integrating Patient Reported Measures as Predictive Parameters into Decision Making about Palliative Chemotherapy: A Pilot Study. BMC Palliative Care, 15, Article No. 25.
https://doi.org/10.1186/s12904-016-0101-z
|
[74]
|
Shrestha, A., Martin, C., Burton, M., Walters, S., Collins, K. and Wyld, L. (2019) Quality of Life versus Length of Life Considerations in Cancer Patients: A Systematic literature Review. Psycho-Oncology, 28, 1367-1380.
https://doi.org/10.1002/pon.5054
|
[75]
|
Younger, E., Jones, R.L., den Hollander, D., Soomers, V., Desar, I., Benson, C., Young, R.J., Oosten, A.W., de Haan, J.J., Miah, A., Zaidi, S., Gelderblom, H., Steeghs, N., Husson, O. and van der Graaf, W.T.A. (2021) Priorities and Preferences of Advanced Soft Tissue Sarcoma Patients Starting Palliative Chemotherapy: Baseline Results from the HOLISTIC Study. ESMO Open, 6, 100258.
https://doi.org/10.1016/j.esmoop.2021.100258
|
[76]
|
Cardenas-Turanzas, M., Gaeta, S., Ashoori, A., Price, K.J. and Nates, J.L. (2011) Demographic and Clinical Determinants of Having Do Not Resuscitate Orders in the Intensive Care Unit of a Comprehensive Cancer Center. Journal of Palliative Medicine, 14, 45-50. https://doi.org/10.1089/jpm.2010.0165
|
[77]
|
Ghandourh, W.A. (2016) Palliative Care in Cancer: Managing Patients’ Expectations. Journal of Medical Radiation Sciences, 63, 242-257.
https://doi.org/10.1002/jmrs.188
|
[78]
|
Buckley de Meritens, A., Margolis, B., Blinderman, C., Prigerson, H.G., Maciejewski, P.K., Shen, M.J., Tergas, A.I., et al. (2017) Practice Patterns, Attitudes, and Barriers to Palliative Care Consultation by Gynecologic Oncologists. Journal of Oncology Practice, 13, e703-e711. https://doi.org/10.1200/JOP.2017.021048
|
[79]
|
CAPC (2021) Center to Advance Palliative Care. About Palliative Care.
https://www.capc.org/about/palliative-care
|
[80]
|
Kobayashi, H., Tsuchiyama, K., Taga, M., Tokunaga, T., Ito, H. and Yokoyama, O. (2021) Impact of Self-Decision to Stop Cancer Treatment on Advanced Genitourinary Cancer Patients. Medicine, 100, e25397.
https://doi.org/10.1097/MD.0000000000025397
|
[81]
|
White, N., Reid, F., Harris, A., Harries, P. and Stone, P. (2016) A Systematic Review of Predictions of Survival In Palliative Care: How Accurate Are Clinicians and Who Are the Experts? PLoS ONE, 11, e0161407.
https://doi.org/10.1371/journal.pone.0161407
|
[82]
|
Utsumi, F., Kajiyama, H., Niimi, K., Sekiya, R., Sakata, J., Suzuki, S., Kikkawa, F., et al. (2017) Clinical Significance and Predicting Indicators of Post-Cancer-Treatment Survival in Terminally Ill Patients with Ovarian Cancer. Journal of Obstetrics and Gynaecology Research, 43, 365-370. https://doi.org/10.1111/jog.13219
|
[83]
|
Wright, A.A., Keating, N.L., Ayanian, J.Z., Chrischilles, E.A., Kahn, K.L., Ritchie, C.S., Weeks, J.C., Earle, C.C. and Landrum, M.B. (2016) Family Perspectives on Aggressive Cancer Care near the End of Life. JAMA, 315, 284-292.
https://doi.org/10.1001/jama.2015.18604
|
[84]
|
Gramling, R., Fiscella, K., Xing, G., Hoerger, M., Duberstein, P., Plumb, S., Mohile, S., Fenton, J.J., Tancredi, D.J., Kravitz, R.L. and Epstein, R.M. (2016) Determinants of Patient-Oncologist Prognostic Discordance in Advanced Cancer. JAMA Oncology, 2, 1421-1426. https://doi.org/10.1001/jamaoncol.2016.1861
|
[85]
|
Matsuyama, R., Reddy, S. and Smith, T.J. (2006) Why Do Patients Choose Chemotherapy near the End of Life? A Review of the Perspective of Those Facing Death from Cancer. Journal of Clinical Oncology, 24, 3490-3496.
https://doi.org/10.1200/JCO.2005.03.6236
|
[86]
|
Ikander, T., Jeppesen, S.S., Hansen, O., Raunkiær, M. and Dieperink, K.B. (2021) Patients and Family Caregivers Report High Treatment Expectations during Palliative Chemotherapy: A Longitudinal Prospective Study. BMC Palliative Care, 20, Article No. 37. https://doi.org/10.1186/s12904-021-00731-4
|
[87]
|
Houck, K., Gallant, J., Avis, N., Fuller, A.F. and Goodman, A. (1999) Quality of Life in Advanced Cancer Patients: Addressing Specific Concerns. Journal of Palliative Medicine, 2, 397-402. https://doi.org/10.1089/jpm.1999.2.397
|
[88]
|
Widera, E.W., Rosenfeld, K.E., Fromme, E.K., Sulmasy, D.P. and Arnold, R.M. (2011) Approaching Patients and Family Members Who Hope for a Miracle. Journal of Pain and Symptom Management, 42, 119-125.
https://doi.org/10.1016/j.jpainsymman.2011.03.008
|
[89]
|
Zier, L.S., Burack, J.H., Micco, G., Chipman, A.K., Frank, J.A. and White, D.B. (2009) Surrogate Decision Makers’ Responses to Physicians’ Predictions of Medical Futility. Chest, 136, 110-117. https://doi.org/10.1378/chest.08-2753
|
[90]
|
Fahmy, D. (2018) Key Findings about Americans’ belief in God. Pew Research Center, Washington DC.
https://www.pewresearch.org/fact-tank/2018/04/25/key-findings-about-americans-belief-in-god
|
[91]
|
Jørgensen, K.J., Hróbjartsson, A. and Gøtzsche, P.C. (2009) Divine Intervention? A Cochrane Review on Intercessory Prayer Gone beyond Science and Reason. Journal of Negative Results in Biomedicine, 8, Article No. 7.
https://doi.org/10.1186/1477-5751-8-7
|
[92]
|
Roberts, J.A., Brown, D., Elkins, T. and Larson, D.B. (1997) Factors Influencing Views of Patients with Gynecologic Cancer about End-of-Life Decisions. American Journal of Obstetrics & Gynecology, 176, 166-172.
https://doi.org/10.1016/S0002-9378(97)80030-0
|
[93]
|
Henselmans, I., Brugel, S.D., de Haes, H., Wolvetang, K., de Vries, L.M., Pieterse, A.H., Baas-Thijssen, M.C., de Vos, F.Y.F., van Laarhoven, H.W.M. and Smets, E.M.A. (2019) Promoting Shared Decision Making in Advanced Cancer: Development and Piloting of a Patient Communication Aid. Patient Education and Counseling, 102, 916-923. https://doi.org/10.1016/j.pec.2018.12.018
|
[94]
|
Glare, P., Virik, K., Jones, M., Hudson, M., Eychmuller, S., Simes, J. and Christakis, N. (2003) A Systematic Review of Physicians’ Survival Predictions in Terminally Ill Cancer Patients. BMJ, 327, Article No. 195.
https://doi.org/10.1136/bmj.327.7408.195
|
[95]
|
Keating, N.L., Landrum, M.B., Rogers Jr., S.O., Baum, S.K., Virnig, B.A., Huskamp, H.A., Kahn, K.L., et al. (2010) Physician Factors Associated with Discussions about End-of-Life Care. Cancer: Interdisciplinary International Journal of the American Cancer Society, 116, 998-1006. https://doi.org/10.1002/cncr.24761
|
[96]
|
Martoni, A.A., Tanneberger, S. and Mutri, V. (2007) Cancer Chemotherapy near the End of Life: The Time Has Come to Set Guidelines for Its Appropriate Use. Tumori, 93, 417-422. https://doi.org/10.1177/030089160709300502
|
[97]
|
Srivastava, R. (2011) Critical Conversations: Navigating between Hope and Truth. The Lancet, 378, 1213-1214. https://doi.org/10.1016/S0140-6736(11)61530-4
|
[98]
|
Balboni, T., Balboni, M., Paulk, M.E., Phelps, A., Wright, A., Peteet, J., Block, S., Lathan, C., Vanderweele, T. and Prigerson, H. (2011) Support of Cancer Patients’ Spiritual Needs and Associations with Medical Care Costs at the End of Life. Cancer, 117, 5383-5391. https://doi.org/10.1002/cncr.26221
|
[99]
|
Buiting, H.M., Rurup, M.L., Wijsbek, H., van Zuylen, L. and den Hartogh, G. (2011) Understanding Provision of Chemotherapy to Patients with End Stage Cancer: Qualitative Interview Study. BMJ (Clinical Research ed.), 342, d1933.
https://doi.org/10.1136/bmj.d1933
|
[100]
|
Emanuel, E.J., Levinsky, N.G., Gazelle, G., Saynina, O. and Ash, A.S. (2003) Chemotherapy Use among Medicare Beneficiaries at the End of Life. Annals of Internal Medicine, 138, 639-643. https://doi.org/10.7326/0003-4819-138-8-200304150-00011
|
[101]
|
Massa, I., Nanni, O., Foca, F., Maltoni, M., Derni, S., Gentili, N., Frassineti, G.L., Casadei Gardini, A., Valgiusti, M., Amadori, D., Prati, E., Altini, M., Gallegati, D. and Sansoni, E. (2018) Chemotherapy and Palliative Care near End-of Life: Examining the Appropriateness at a Cancer Institute for Colorectal Cancer Patients. BMC Palliative Care, 17, Article No. 86. https://doi.org/10.1186/s12904-018-0339-8
|
[102]
|
Yeh, J.C., Knight, L.S., Kane, J., Doberman, D.J., Gupta, A. and Smith, T.J. (2019) Has There Been a Shift in Use of Subacute Rehabilitation Instead of Hospice Referral Since Immunotherapy Has Become Available? Journal of Oncology Practice, 15, e849-e855. https://doi.org/10.1200/JOP.19.00044
|
[103]
|
Lang, F. and Quill, T. (2004) Making Decisions with Families at the End of Life. American Family Physician, 70, 719-723.
|
[104]
|
Parker, S.M., Clayton, J.M., Hancock, K., Walder, S., Butow, P.N., Carrick, S., Currow, D., Ghersi, D., Glare, P., Hagerty, R. and Tattersall, M.H. (2007) A Systematic Review of Prognostic/End-of-Life Communication with Adults in the Advanced Stages of a Life-Limiting Illness: Patient/Caregiver Preferences for the Content, Style, and Timing of Information. Journal of Pain and Symptom Management, 34, 81-93. https://doi.org/10.1016/j.jpainsymman.2006.09.035
|
[105]
|
Norton, S.A., Metzger, M., DeLuca, J., Alexander, S.C., Quill, T.E. and Gramling, R. (2013) Palliative Care Communication: Linking Patients’ Prognoses, Values, and Goals of Care. Research in Nursing & Health, 36, 582-590.
https://doi.org/10.1002/nur.21563
|
[106]
|
Christakis, N.A. and Lamont, E.B. (2000) Extent and Determinants of Error in Doctors’ Prognoses in Terminally Ill Patients: Prospective Cohort Study. BMJ (Clinical Research ed.), 320, 469-472. https://doi.org/10.1136/bmj.320.7233.469
|
[107]
|
Back, A.L. anderson, W.G., Bunch, L., Marr, L.A., Wallace, J.A., Yang, H.B. and Arnold, R.M. (2008) Communication about Cancer near the End of Life. Cancer, 113, 1897-1910. https://doi.org/10.1002/cncr.23653
|
[108]
|
Winkler, E.C., Hiddemann, W. and Marckmann, G. (2012) Evaluating a Patient’s Request for Life-Prolonging Treatment: An Ethical Framework. Journal of Medical Ethics, 38, 647-651. https://doi.org/10.1136/medethics-2011-100333
|
[109]
|
White, N., Harries, P., Harris, A.J., Vickerstaff, V., Lodge, P., McGowan, C., Stone, P., et al. (2018) How Do Palliative Care Doctors Recognise Imminently Dying Patients? A Judgement Analysis. BMJ Open, 8, e024996.
https://doi.org/10.1136/bmjopen-2018-024996
|
[110]
|
Adamson, M., Choi, K., Notaro, S. and Cotoc, C. (2018) The Doctor-Patient Relationship and Information-Seeking Behavior: Four Orientations to Cancer Communication. Journal of Palliative Care, 33, 79-87.
https://doi.org/10.1177/0825859718759881
|
[111]
|
Dzeng, E., Colaianni, A., Roland, M., Chander, G., Smith, T.J., Kelly, M.P., Levine, D., et al. (2015) Influence of Institutional Culture and Policies on Do-Not-Resuscitate Decision Making at the End of Life. JAMA Internal Medicine, 175, 812-819.
https://doi.org/10.1001/jamainternmed.2015.0295
|
[112]
|
Cherny, N.I., Catane, R. and European Society of Medical Oncology Taskforce on Palliative and Supportive Care (2003) Attitudes of Medical Oncologists toward Palliative Care for Patients with Advanced and Incurable Cancer: Report on a Survey by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care. Cancer, 98, 2502-2510. https://doi.org/10.1002/cncr.11815
|
[113]
|
Zimmermann, C., Swami, N., Krzyzanowska, M., Hannon, B., Leighl, N., Oza, A., Donner, A., et al. (2014) Early Palliative Care for Patients with Advanced Cancer: A Cluster-Randomised Controlled Trial. The Lancet, 383, 1721-1730.
https://doi.org/10.1016/S0140-6736(13)62416-2
|
[114]
|
Hugar, L.A., Wulff-Burchfield, E.M., Winzelberg, G.S., et al. (2021) Incorporating Palliative Care Principles to Improve Patient Care and Quality of Life in Urologic Oncology. Nature Reviews Urology, 18, 623-635.
https://doi.org/10.1038/s41585-021-00491-z
|
[115]
|
Brown, A.J., Shen, M.J., Urbauer, D., Taylor, J., Parker, P.A., Carmack, C., Ramondetta, L., et al. (2016) Room for Improvement: An Examination of Advance Care Planning Documentation among Gynecologic Oncology Patients. Gynecologic Oncology, 142, 525-530. https://doi.org/10.1016/j.ygyno.2016.07.010
|
[116]
|
Kaasa, S., Loge, J.H., Aapro, M., Albreht, T. anderson, R., Bruera, E., Deliens, L., et al. (2018) Integration of Oncology and Palliative Care: A Lancet Oncology Commission. The Lancet Oncology, 19, e588-e653.
https://doi.org/10.1016/S1470-2045(18)30415-7
|
[117]
|
Salins, N., Ghoshal, A., Hughes, S., et al. (2020) How Views of Oncologists and Haematologists Impacts Palliative Care Referral: A Systematic Review. BMC Palliative Care 19, 175. https://doi.org/10.1186/s12904-020-00671-5
|
[118]
|
Kash, K.M., Holland, J.C., Breitbart, W., Berenson, S., Dougherty, J., Ouellette-Kobasa, S. and Lesko, L. (2000) Stress and Burnout in Oncology. Oncology (Williston Park), 14, 1621-1633.
|
[119]
|
De la Fuente-Solana, E.I., Pradas-Hernández, L., Ramiro-Salmerón, A., Suleiman-Martos, N., Gómez-Urquiza, J.L., Albendín-García, L. and Cañadas-De la Fuente, G.A. (2020) Burnout Syndrome in Paediatric Oncology Nurses: A Systematic Review and Meta-Analysis. Healthcare (Basel), 8, Article No. 309.
https://doi.org/10.3390/healthcare8030309
|
[120]
|
Shayne, M. and Quill, T.E. (2012) Oncologists Responding to Grief. Archives of Internal Medicine, 172, 966-967. https://doi.org/10.1001/archinternmed.2012.2035
|
[121]
|
Díaz-Montes, T.P., Johnson, M.K., Giuntoli, R.L. and Brown, A.J. (2013) Importance and Timing of End-of-Life Care Discussions among Gynecologic Oncology Patients. American Journal of Hospice and Palliative Medicine®, 30, 59-67.
https://doi.org/10.1177/1049909112444156
|
[122]
|
Mullen, M.M., Cripe, J.C. and Thaker, P.H. (2019) Palliative Care in Gynecologic Oncology. Obstetrics and Gynecology Clinics, 46, 179-197.
https://doi.org/10.1016/j.ogc.2018.10.001
|
[123]
|
Einav, L., Finkelstein, A., Mullainathan, S. and Obermeyer, Z. (2018) Predictive Modeling of US Health Care Spending in Late Life. Science, 360, 1462-1465.
https://doi.org/10.1126/science.aar5045
|
[124]
|
Wu, E., Rogers, A., Ji, L., Sposto, R., Church, T., Roman, L., Lin, Y.G., et al. (2015) Escalation of Oncologic Services at the End of Life among Patients with Gynecologic Cancer at an Urban, Public Hospital. Journal of Oncology Practice, 11, e163-e169.
https://doi.org/10.1200/JOP.2014.001529
|
[125]
|
Bliton, J.N., Parides, M., Muscarella, P., Papalezova, K.T. and In, H. (2021) Understanding Racial Disparities in Gastrointestinal Cancer Outcomes: Lack of Surgery Contributes to Lower Survival in African American Patients. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, 30, 529-538. https://doi.org/10.1158/1055-9965.EPI-20-0950
|
[126]
|
Brule, S.Y., Al-Baimani, K., Jonker, H., Zhang, T., Nicholas, G., Goss, G., Laurie, S.A. and Wheatley-Price, P. (2016) Palliative Systemic Therapy for Advanced Non-Small Cell Lung Cancer: Investigating Disparities between Patients Who Are Treated versus Those Who Are Not. Lung Cancer, 97, 15-21.
https://doi.org/10.1016/j.lungcan.2016.04.007
|
[127]
|
Mullins, M.A., Ruterbusch, J.J., Clarke, P., Uppal, S., Wallner, L.P. and Cote, M.L. (2021) Trends and Racial Disparities in Aggressive End-of-Life Care for a National Sample of Women with Ovarian Cancer. Cancer, 127, 2229-2237.
https://doi.org/10.1002/cncr.33488
|
[128]
|
Trevino, K.M., Zhang, B., Shen, M.J. and Prigerson, H.G. (2016) Accuracy of Advanced Cancer Patients’ Life Expectancy Estimates: The Role of Race and Source of Life Expectancy Information. Cancer, 122, 1905-1912.
https://doi.org/10.1002/cncr.30001
|
[129]
|
Perry, L.M., Walsh, L.E., Horswell, R., et al. (2021) Racial Disparities in End-of-Life Care between Black and White Adults with Metastatic Cancer. Journal of Pain and Symptom Management, 61, 342-349.E1.
https://doi.org/10.1016/j.jpainsymman.2020.09.017
|
[130]
|
Penner, L.A., Dovidio, J.F., Gonzalez, R., et al. (2016) The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions. Journal of Clinical Oncology, 34, 2874-2880. https://doi.org/10.1200/JCO.2015.66.3658
|
[131]
|
Von Roenn, J.H. (2019) Is Implicit Bias Contributing to Time Disparities in Goals-of-Care Conversations with Minority Patients? A Conversation with Cardinale B. Smith, MD, PhD. The ASCO Post.
https://ascopost.com/news/september-2019/is-implicit-bias-contributing-to-time-disparities-in-conversations-with-minority-pa
|
[132]
|
Murphy, M.M., Simons, J.P., Ng, S.C., McDade, T.P., Smith, J.K., Shah, S.A., Zhou, Z., Earle, C.C. and Tseng, J.F. (2009) Racial Differences in Cancer Specialist Consultation, Treatment, and Outcomes for Locoregional Pancreatic Adenocarcinoma. Annals of Surgical Oncology, 16, 2968-2977.
https://doi.org/10.1245/s10434-009-0656-5
|
[133]
|
Rajagopal, P.S., Nipp, R.D. and Selvaggi, K.J. (2014) Chemotherapy for Advanced Cancers. Annals of Palliative Medicine, 3, 203-228.
|
[134]
|
Tsubamoto, H., Ito, Y., Kanazawa, R., Wada, R., Hosoda, Y., Honda, O., Shibahara, H., et al. (2014) Benefit of Palliative Chemotherapy and Hospice Enrollment in Late-Stage Ovarian Cancer Patients. Journal of Obstetrics and Gynaecology Research, 40, 1399-1406. https://doi.org/10.1111/jog.12320
|
[135]
|
Murakawa, Y., Sakayori, M. and Otsuka, K. (2019) Impact of Palliative Chemotherapy and Best Supportive Care on Overall Survival and Length of Hospitalization in Patients with Incurable Cancer: A 4-Year Single Institution Experience in Japan. BMC Palliative Care, 18, Article No. 45.
https://doi.org/10.1186/s12904-019-0428-3
|
[136]
|
Donnelly, S., Prizeman, G., Coimín, D.ó., et al. (2018) Voices That Matter: End-of-Life Care in Two Acute Hospitals from the Perspective of Bereaved Relatives. BMC Palliative Care, 17, Article No. 117. https://doi.org/10.1186/s12904-018-0365-6
|
[137]
|
Epstein, R.M., Alper, B.S. and Quill, T.E. (2004) Communicating Evidence for Participatory Decision Making. JAMA, 291, 2359-2366.
https://doi.org/10.1001/jama.291.19.2359
|
[138]
|
Epstein, R.M., Duberstein, P.R., Fenton, J.J., Fiscella, K., Hoerger, M., Tancredi, D.J., Xing, G., Gramling, R., Mohile, S., Franks, P., Kaesberg, P., Plumb, S., Cipri, C.S., Street, R.L., Shields, C.G., Back, A.L., Butow, P., Walczak, A., Tattersall, M., Venuti, A., Sullivan, P., Robinson, M., Hoh, B., Lewis, L. and Kravitz, R.L. (2017) Effect of a Patient-Centered Communication Intervention on Oncologist-Patient Communication, Quality of Life, and Health Care Utilization in Advanced Cancer: The VOICE Randomized Clinical Trial. JAMA Oncology, 3, 92-100.
https://doi.org/10.1001/jamaoncol.2016.4373
|
[139]
|
Foote, J., Lopez-Acevedo, M., Samsa, G., Lee, P.S., Kamal, A.H., Secord, A.A. and Havrilesky, L.J. (2018) Predicting 6- and 12-Month Risk of Mortality in Patients with Platinum-Resistant Advanced-Stage Ovarian Cancer: Prognostic Model to Guide Palliative Care Referrals. International Journal of Gynecologic Cancer, 28, 302-307. https://doi.org/10.1097/IGC.0000000000001182
|
[140]
|
Scarborough, B.M. and Smith, C.B. (2018) Optimal Pain Management for Patients with Cancer in the Modern Era. CA: A Cancer Journal for Clinicians, 68, 182-196.
https://doi.org/10.3322/caac.21453
|
[141]
|
Walling, A.M., Asch, S.M., Lorenz, K.A., et al. (2012) The Quality of Supportive Care among Inpatients Dying with Advanced Cancer. Supportive Care in Cancer, 20, 2189-2194. https://doi.org/10.1007/s00520-012-1462-3
|
[142]
|
Carolan, C.M., Smith, A., Davies, G.R. and Forbat, L. (2018) Seeking, Accepting and Declining Help for Emotional Distress in Cancer: A Systematic Review and Thematic Synthesis of Qualitative Evidence. European Journal of Cancer Care, 27, e12720. https://doi.org/10.1111/ecc.12720
|
[143]
|
Spiegel, D. (2012) Mind Matters in Cancer Survival. Psycho-Oncology, 21, 588-593.
https://doi.org/10.1002/pon.3067
|
[144]
|
Meropol, N., Egleston, B.L., Buzaglo, J.S., Benson, A.B., Cegala, D.J., Diefenbach, M.A., Fleisher, L., Miller, S.M., Sulmasy, D.P., Weinfurt, K.P. and CONNECT Study Research Group (2008) Cancer Patient Preferences for Quality and Length of Life. Cancer, 113, 3459-3466. https://doi.org/10.1002/cncr.23968
|
[145]
|
Chan, W.L., Lam, K.O., Siu, W.K. and Yuen, K.K. (2016) Chemotherapy at End-of-Life: An Integration of Oncology and Palliative Team. Supportive Care in Cancer, 24, 1421-1427. https://doi.org/10.1007/s00520-015-3031-z
|
[146]
|
Greer, J.A., Pirl, W.F., Jackson, V.A., Muzikansky, A., Lennes, I.T., Heist, R.S., Gallagher, E.R. and Temel, J.S. (2012) Effect of Early Palliative Care on Chemotherapy Use and End-of-Life Care in Patients with Metastatic Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 30, 394-400.
https://doi.org/10.1200/JCO.2011.35.7996
|
[147]
|
Lee, S.W., Jho, H.J., Baek, J.Y., Shim, E.K., Kim, H.M., Ku, J.Y., Nam, E.J., Chang, Y.J., Choi, H.J. and Kim, S.Y. (2018) Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal Cancer. American Journal of Hospice and Palliative Care, 35, 166-172.
https://doi.org/10.1177/1049909116689459
|
[148]
|
Lees, C., Weerasinghe, S., Lamond, N., Younis, T. and Ramjeesingh, R. (2019) Palliative Care Consultation and Aggressive Care at End of Life in Unresectable Pancreatic Cancer. Current Oncology (Toronto, Ont.), 26, 28-36.
https://doi.org/10.3747/co.26.4389
|
[149]
|
Morita, T., Akechi, T., Ikenaga, M., et al. (2005) Late Referrals to Specialized Palliative Care Service in Japan. Journal of Clinical Oncology, 23, 2637-2644.
https://doi.org/10.1200/JCO.2005.12.107
|
[150]
|
Rego, F., Gonçalves, F., Moutinho, S., et al. (2020) The Influence of Spirituality on Decision-Making in Palliative Care Outpatients: A Cross-Sectional Study. BMC Palliative Care, 19, Article No. 22. https://doi.org/10.1186/s12904-020-0525-3
|
[151]
|
Saha, S., Beach, M.C. and Cooper, L.A. (2008) Patient Centeredness, Cultural Competence and Healthcare Quality. Journal of the National Medical Association, 100, 1275-1285. https://doi.org/10.1016/S0027-9684(15)31505-4
|
[152]
|
Childers, J.W., Back, A.L., Tulsky, J. and Arnold, R.M. (2017) REMAP: A Framework for Goals of Care Conversations. Journal of Oncology Practice, 13, e844-e850. https://doi.org/10.1200/JOP.2016.018796
|
[153]
|
VitalTalk (2019) Addressing Goals of Care: Using the REMAP Tool.
https://www.vitaltalk.org/guides/transitionsgoals-of-care
|
[154]
|
Messerotti, A., Banchelli, F., Ferrari, S., et al. (2020) Investigating the Association between Physicians Self-Efficacy Regarding Communication Skills and Risk of “Burnout”. Health and Quality of Life Outcomes, 18, Article No. 271.
https://doi.org/10.1186/s12955-020-01504-y
|